-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

613A.O2.6 613. Acute Myeloid Leukemias: Clinical and Epidemiological: Real World Outcomes and Treatment Approaches

Symposia: Acute Myeloid Leukemias: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, epidemiology, Clinical Research, real-world evidence
Sunday, December 10, 2023: 4:30 PM-6:00 PM
Pacific Ballroom Salons 24-26 (Marriott Marquis San Diego Marina)
Moderators:
Reena Jayani, MD, Vanderbilt University Medical Center and Andrew M. Brunner, MD, Massachusetts General Hospital, Harvard Medical School
Disclosures:
Brunner: Acceleron: Consultancy; Agios: Consultancy, Research Funding; AstraZeneca: Research Funding; Celgene/BMS: Consultancy, Research Funding; GSK: Research Funding; Janssen: Research Funding; Keros Therapeutics: Consultancy; Novartis: Consultancy, Research Funding; Taiho: Consultancy; Takeda: Consultancy; Gilead: Consultancy.
4:30 PM

Cameron Hunter1, Wei Cheng, PhD2*, Stephanie Halene, MD1, Lourdes Mendez, MD1*, Nikolai A. Podoltsev, MD, PhD3, Amer M. Zeidan, MBBS, MHS4, Lisa Barbarotta, APRN1* and Rory M. Shallis, MD5

1Section of Hematology, Department of Internal Medicine, Yale School of Medicine - Yale Cancer Center, New Haven, CT
2Department of Biostatistics, Yale School of Public Health, New Haven, CT
3Associate Professor of Medicine, Department of Hematology, Yale School of Medicine, New Haven, CT
4Section of Hematology, Department of Internal Medicine, Yale University School of Medicine - Yale Cancer Center, New Haven, CT
5Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, Killingworth, CT

4:45 PM

Zofia Gross1*, Urbain Tauveron-Jalenques2*, Gaspar Aspas Requena, MD3*, Martin Carre, MD4*, Mathieu Meunier, MD, PhD5*, Emmanuelle Tavernier, MD6*, Jérôme Cornillon, MD7*, Amine Belhabri, MD8*, Mauricette Michallet, MD, PhD9, Adrien Contejean, MD10*, Natacha Mauz11*, Boullanger FOW HENG Nadine12*, Daciana Claudia Antal13*, Gian Matteo Pica14*, Dony Arthur14*, Clémence Santana15*, Clement Rocher16* and Mael Heiblig17*

1Hematology Department, Hopital Lyon Sud, Pierre Bénite, France
2Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France
3Hématologie, Centre Hospitalier Universitaire Clermont-Ferrand, Clermont-Ferrand, France
4Clinical Hematology Department, CHU Grenoble Alpes - Université Grenoble Alpes, Grenoble, France
5Clinique Universitaire d’hématologie, Université de Grenoble-Alpes, CHU de Grenoble, Grenoble, France
6Institut De Cancérologie De La Loire, Saint Priest En Jarez, FRA
7Département d’hématologie clinique et de thérapie cellulaire, CHU de St-Étienne, Saint-Étienne, France
8Centre Leon Berard, Lyon, FRA
9Centre Leon Berard, Lyon, France
10Hématologie, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, FRA
11Department of Hematology, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France
12Hématologie, CENTRE HOSPITALIER DE ROANNE, ROANNE, France
13Hématologie, Centre Hospitalier de Roanne, Roanne, France
14Hématologie, Centre Hospitalier Métropole Savoie, Chambéry, France
15Hématologie, Centre Hospitalier de Valence, Valence, France
16Hématologie, Centre Hospitalier Bourgoin Jallieu, Bourgoin Jallieu, FRA
17Hematology Department, Hôpital Lyon Sud, Vourles, Rhône Alpes, France

5:00 PM

Omer Karrar1*, Moazah Iftikhar1*, Kristen McCullough, PharmD2, Isla Johnson, MD3, Maymona Abdelmagid4*, Aref Al-Kali, MD1, Hassan Alkhateeb, MD1*, Kebede Begna, MD1, Abhishek A Mangaonkar, MBBS1, Antoine Saliba, MD1, Mehrdad Hefazi, MD1, Mark R. Litzow, MD1, William J. Hogan, MD1, Mithun V Shah, MD, PhD1, Mrinal M. Patnaik, MD, MBBS5, Animesh D. Pardanani, MBBS, PhD1, Talha Badar, MD6, Hemant S. Murthy, MD7, James M. Foran, MD8, Jeanne Palmer, MD9, Lisa Sproat, MD10, Nandita Khera, MD11, Cecilia Y. Arana Yi, MD12, Ayalew Tefferi, MD1 and Naseema Gangat, MBBS1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Mayo Clinic, Rochester, MN
3Mayo School of Graduate Medical Education,, Rochester, MN
4Division of Hematology, Mayo Clinic, Rochester, MN, USA., Rochester, MN
5Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
6Mayo Clinic, Jacksonville, FL
7Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL
8Hematology/Oncology, Mayo Clinic, Jacksonville, FL
9Mayo Clinic - Arizona, Scottsdale, AZ
10Banner Blood & Marrow Transplant Prgm., Phoenix, AZ
11Mayo Clinic, Phoenix, AZ
12Hematology/Oncology, Mayo Clinic, Scottsdale, AZ

5:15 PM

Talha Badar, MD1, Ehab L. Atallah, MD2, Rory M. Shallis, MD3, Anand Ashwin Patel, MD4, Guilherme Sacchi De Camargo Correia, MD5, Aaron D. Goldberg, MD, PhD6, Antoine Saliba, MD7, Jan Philipp Bewersdorf, MD8, Adam S Duvall, MD9, Danielle Bradshaw, MD10*, Yasmin Abaza, MD11, Guru Subramanian Guru Murthy, MD2,12*, Neil Palmisiano, MD, MS13, Vamsi K. Kota, MD14 and Mark R. Litzow, MD7

1Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL
2Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
3Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, Killingworth, CT
4Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
5Mayo Clinic, Jacksonville, FL
6Memorial Sloan Kettering Cancer Center, New York, NY
7Division of Hematology, Mayo Clinic, Rochester, MN
8Department of Medicine, Section of Hematology, Yale University, New Haven, CT
9Department of Medicine, University of Chicago, Chicago, IL
10Augusta University, Augusta, GA
11Northwestern Medicine, Chicago, IL
12Medical College of Wisconsin, Milwaukee
13Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PA
14Georgia Cancer Center, Augusta University, Augusta, GA

5:30 PM

David L. Grinblatt, MD1, Gail J. Roboz, MD2, Daniel A. Pollyea, MD, MS3, Mikkael A. Sekeres, MD4, Bart L. Scott, MD5, Karen Seiter, MD6, Amer M. Zeidan, MBBS, MHS7, Jay M Patel, PharmD BCOP8, Guillermo Garcia-Manero, MD9, Rami S. Komrokji, MD10, Michael R. Savona, MD11, Irene S. Degutis, PharmD12*, Pavel Kiselev, PhD12*, Edward Yu, ScD12*, Willem Heydendael, PhD12*, Ying Qiu, PhD12*, Sara Vergara, MD12*, Ali McBride, PharmD12 and Harry P. Erba, MD, PhD13

1NorthShore University HealthSystem, Evanston, IL
2Weill Cornell Medicine, The New York Presbyterian Hospital, New York, NY
3University of Colorado, Aurora, CO
4Sylvester Cancer Center, University of Miami, Miami, FL
5Fred Hutchinson Cancer Center, Seattle, WA
6New York Medical College, Valhalla, NY
7Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, CT
8Adaptive Biotechnologies, Salt Lake City, UT
9University of Texas MD Anderson Cancer Center, Houston, TX
10Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
11Vanderbilt Ingram Cancer Center, Nashville, TN
12Bristol Myers Squibb, Princeton, NJ
13University of Alabama At Birmingham, Durham, NC

5:45 PM

James M. Foran, MD1, Li Chen, MS2*, Selina M Luger, MD, FRCPC3, Zhuoxin Sun, PhD4*, Heidi Klepin, MD5, David F. Claxton, MD6, Hillard M. Lazarus, MD7, Jacob M. Rowe, MB, BS8, Jessica K. Altman, MD9, Aref Al-Kali, MD10, Hong Zheng, MD, PhD6, Keith W Pratz, MD11, Edward R. Broun, MD12*, Bayard L Powell, MD13, Kristen M. O'Dwyer, MD14, Yishai Ofran, MD15, John E. Godwin, MD16*, Mark R. Litzow, MD17, Martin S. Tallman, MD18 and Lynne Wagner, PhD19*

1Division of Hematology & Medical Oncology, Mayo Clinic Florida, Jacksonville, FL
2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
3Perelman School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
4Dana-Farber Cancer Institute, Boston, MA
5Wake Forest University School of Medicine, Winston Salem, NC
6Penn State Cancer Institute, Hershey, PA
7Case Western Reserve University, Cleveland, OH
8Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel
9Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
10Mayo Clinic, Rochester, MN
11Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
12OHC, Inc., Cincinnati, OH
13Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC
14University of Rochester Medical Center, Rochester, NY
15Department of Hematology and Bone Marrow Transplant, Sharee Zedek Medical Center, Jerusalem, Israel
16Providence Portland Medical Center, Portland, OR
17Division of Hematology, Mayo Clinic, Rochester, MN
18Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Highland Park, IL
19Department of Health Policy and Management, UNC Gillings School of Global Public Health, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC

*signifies non-member of ASH